Kostiantyn Turcheniukab,
Manakamana Khanala,
Anastasiia Motorinaac,
Palaniappan Subramaniana,
Alexandre Barrasa,
Vladimir Zaitsevc,
Victor Kuncserd,
Aurel Lecad,
Alain Martoriatie,
Katia Cailliaue,
Jean-Francois Bodarte,
Rabah Boukherrouba and
Sabine Szunerits*a
aInstitut de Recherche Interdisciplinaire (IRI, USR CNRS 3078), Université Lille 1, Parc de la Haute Borne, 50 Avenue de Halley, BP 70478, 59658 Villeneuve d'Ascq, France. E-mail: Sabine.Szunerits@iri.univ-lille1.fr
bDepartment of Fine Organic Synthesis, Institute of Bioorganic Chemistry and Petrochemistry NAS of Ukraine, 1 Murmanska Str., 02660, Kiev, Ukraine
cTaras Shevchenko University, 60 Vladimirskaya str., Kiev, Ukraine
dNational Institute of Materials Physics, Atomistilor 105 bis, 077125 Magurele, Romania
eEA 4479, IFR 147, Université Lille 1, 59658 Villeneuve d'Ascq, France
First published on 6th December 2024
Expression of concern for ‘Insulin loaded iron magnetic nanoparticle–graphene oxide composites: synthesis, characterization and application for in vivo delivery of insulin’ by Kostiantyn Turcheniuk et al., RSC Adv., 2014, 4, 865–875, https://doi.org/10.1039/C3RA46307A.
Laura Fisher
5th November 2024
Executive Editor, RSC Advances
This journal is © The Royal Society of Chemistry 2024 |